Pérez-Madrid C, Chiquito-García S, Uribe-Bojanini E, Jiménez-Tamayo SE

Idioma: Español
Referencias bibliográficas: 58
Paginas: 114-121
Archivo PDF: 144.82 Kb.

RESUMEN

La fototerapia es una terapia ampliamente utilizada en pacientes con psoriasis. Su efectividad ha sido comprobada por la reducción del PASI (índice de severidad del área de psoriasis) y los resultados son comparables a los alcanzados con otras terapias de mayor costo y más efectos adversos. Esta revisión pretende mostrar evidencia acerca de las bondades, indicaciones y contraindicaciones de la fototerapia, la cual es un tratamiento costo-efectividad que puede ser empleada como monoterapia o como tratamiento combinado con otros medicamentos tópicos y/o sistémicos. En la actualidad han venido incursionando nuevas tecnologías, a pesar de esto, la fototerapia sigue teniendo vigencia y su uso continua estando indicado.

REFERENCIAS (EN ESTE ARTÍCULO)

1. González C, Londoño A y Castro L (eds.), Guías basadas en la evidencia para el manejo de la psoriasis en Colombia, Bogotá, Panamericana, 2012.

2. Vaño-Galvann S, Garate MT, Fleta-Asinn B et al., Análisis coste-efectividad de la fototerapia domiciliaria con ultravioleta B de banda estrecha frente a fármacos biológicos en el tratamiento de la psoriasis moderada- grave, Actas Dermosifiliogr 2012; 103(2): 127-37.

3. Hung R, Ungureanu S, Edwards C et al., Home phototherapy for psoriasis: a review and update, Clin Exp Dermatol 2015; 40(8): 827-33.

4. Inzinger M, Heschl B, Weger W et al., Efficacy of psoralen plus ultraviolet. A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry, Br J Dermatol 2011; 165(3): 640-5.

5. Beyer V y Wolverton SE, Recent trends in systemic psoriasis treatment costs, Arch Dermatol 2010; 146(1): 46-54.

6. Hönigsmann H, History of phototherapy in dermatology, Photochem Photobiol Sci 2012; 12(1): 16-21.

7. Racz E y Prens EP, Phototherapy and photochemotherapy for psoriasis, Dermatol Clin 2015; 33(1) :79-89.

8. Kragballe K, Hölzle E Van de Kerkhof PCM y Philipp S, Treatment of plaque psoriasis, en Psoriasis: diagnosis and management, 2015, pp. 163-213.

9. Chen X, Yang M, Cheng Y et al., Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet A or psoralen-ultraviolet A photochemotherapy for psoriasis, Cochrane Database Syst Rev, 2013.

10. Martínez M, Levrero P, Carusso R y Morales C, Psoriasis vulgar moderada y severa: opciones terapéuticas (tratamientos convencionales), Arch Med Interna 2013; 35(3): 93-100.

11. Totonchy MB y Chiu MW, UV-based therapy, Dermatol Clin 2014; 32(3): 399-413.

12. Ubogui JG y Saposnik M, Fototerapia ultravioleta en dermatología, Dermatol Argent 2008; 4(4): 267-75.

13. Coimbra S, Oliveira H, Reis F et al., Interleukin IL-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy, Br J Dermatol 2010; 163(6): 1282-90.

14. Batycka-Baran A, Besgen P, Wolf R et al., The effect of phototherapy on systemic inflammatory process in patients with plaque psoriasis, J Photochem Photobiol B Biol 2016; 161: 396-401.

15. Meola T, Soter NA y Lim HW, Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature, Arch Dermatol 1991; 127(11): 1708-13.

16. Menter A, Korman NJ, Elmets CA et al., Guidelines of care for the management of psoriasis and psoriatic arthritis: section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy, J Am Acad Dermatol 2010; 62(1): 114-35.

17. Menter MA, See JA, Amend WJ et al., Proceedings of the psoriasis combination and rotation therapy conference, Deer Valley, Utah, 7-9 de octubre de 1994, J Am Acad Dermatol 1996; 34(2 Pt 1): 315-21.

18. Ramsay CA, Schwartz BE, Lowson D et al., Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and uvb-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group, Dermatology 2000; 200(1): 17-24.

19. Ashcroft DM, Li Wan Po A, Williams HC y Griffiths CE, Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability, Arch Dermatol 2000; 136(12): 1536-43.

20. Nast A, Boehncke WH, Mrowietz U et al., German S3-guidelines on the treatment of psoriasis vulgaris (short version), Arch Dermatol Res 2012; 304(2): 87-113.

21. Torras H, Aliaga A, López-Estebaranz JL et al., A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris, J Dermatolog Treat 2004; 15(2): 98-103.

22. Koo JY, Lowe NJ, Lew-Kaya DA et al., Tazarotene plus UVB phototherapy in the treatment of psoriasis, J Am Acad Dermatol 2000; 43(5 Pt 1): 821-8.

23. Tzaneva S, Hönigsmann H, Tanew A y Seeber A, A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis, Br J Dermatol 2002; 147(4): 748-53.

24. Asawanonda P y Nateetongrungsak Y, Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebocontrolled study, J Am Acad Dermatol, 2006, 54(6): 1013-1018.

25. Ozdemir M, Engin B, Baysal I et al., A randomized comparison of acitretin-narrow-band TL -01 phototherapy and acitretin-psoralen plus ultraviolet a for psoriasis, Acta Derm Venereol 2008; 88(6): 589-93.

26. Menter A, Korman N, Elmets C et al., Guidelines of care for the management of psoriasis and psoriatic arthritis, J Am Dermatology 2009; 60(4): 643-59, disponible en: http://dx.doi.org/10.1016/j. jaad.2008.12.032.

27. Nijsten TEC y Stern RS, Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen- UVA: a nested cohort study, J Am Acad Dermatol 2003; 49(4): 644-50.

28. Kircik L, Bagel J, Korman N et al., Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes, J Drugs Dermatol 2008; 7(3): 245-53.

29. Calzavara-Pinton PG, Sala R, Arisi M et al., Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis, Br J Dermatol 2013; 169(1): 130-6.

30. Wolf P, Weger W, Legat FJ et al., Treatment with 311-nm ultraviolet b enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial, Br J Dermatol 2012; 166(1): 147-53.

31. Naldi L, Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies, Clin Dermatol 2010; 28(1): 88-92.

32. Wolfe F y Michaud K, Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study, Arthritis Rheum 2007; 56(9): 2886-95.

33. Sigurdardottir G, Ekman AK, Ståhle M et al., Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis, J Am Acad Dermatol 2014; 70(6): 1067-75.

34. Dujic J, Kippenberger S, Hoffmann S et al., Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light, J Invest Dermatol 2007; 127(8): 1992-2000.

35. Dujic J, Kippenberger S, Ramírez-Bosca A et al., Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model, Int J Cancer 2009; 124(6): 1422-1428.

36. Carrión-Gutiérrez M, Ramírez-Bosca A, Navarro-López V et al., Effects of curcuma extract and visible light on adults with plaque psoriasis, Eur J Dermatol 2015; 25(3): 240-6.

37. Lim HW, Silpa-Archa N, Amadi U et al., Phototherapy in dermatology: a call for action, J Am Acad Dermatol 2015; 72(6): 1078-80.

38. Kawada A, Evolution of targeted phototherapy for psoriasis, Expert Rev Dermatol 2013; 8(6): 623-9.

39. Goldinger SM, Dummer R, Schmid P et al., Excimer laser versus narrow- band UVB (311 nm) in the treatment of psoriasis vulgaris, Dermatology 2006; 213(2): 134-9.

40. Almutawa F, Thalib L, Hekman D et al., Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis, Photodermatol Photoimmunol Photomed 2015; 31(1): 5-14.

41. Beggs S, Short J, Rengifo-Pardo M y Ehrlich A, Applications of the excimer laser: a review, Dermatol Surg 2015; 41(11): 1201-11.

42. Lapolla W, Yentzer BA, Bagel J et al., A review of phototherapy protocols for psoriasis treatment, J Am Acad Dermatol 2011; 64: 936-49.

43. Berneburg M, Röcken M y Benedix F, Phototherapy with narrowband vs broadband UVB, Acta Dermato-Venereol 2005; 85: 98-108.

44. Osorio F y Magina S, Phototherapy and photopheresis: old and new indications, Expert Rev Dermatol 2011; 6(6): 613-23.

45. Gerber W, Arheilger B, Ha TA et al., Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach, Br J Dermatol 2003; 149(6): 1250-8.

46. Bónis B, Kemény L, Dobozy A et al., 308 nm UVB excimer laser for psoriasis, Lancet 1997; 350(9090): 1522.

47. Köllner K, Wimmershoff MB, Hintz C et al., Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis, Br J Dermatol 2005; 152(4): 750-4.

48. Stein KR, Pearce DJ y Feldman SR, Targeted UV therapy in the treatment of psoriasis, J Dermatolog Treat 2008; 19(3): 141-5.

49. Bianchi B, Campolmi P, Mavilia L et al., Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis, J Eur Acad Dermatol Venereol 2003; 17(4): 408-13.

50. Kagen M, Cao LY, Oyetakin-White P et al., Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T cell subsets in psoriasis, Photodermatol Photoimmunol Photomed 2012; 28(6): 293-8.

51. Anderson KL y Feldman SR, A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles, J Am Acad Dermatol 2015; 72(5): 868-78.e1.

52. Bhutani T y Liao W, A practical approach to home UVB phototherapy for the treatment of generalized psoriasis, Pract dermatology 2010; 7(2): 31-5.

53. Sarkany R, Anstey A, Diffey B et al., Home phototherapy: report on a workshop of the British Photodermatology Group, December 1996, Br J Dermatol 1999; 140(2): 195-9.

54. Koek MBG, Buskens E, Van Weelden H et al., Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study), BMJ 2009; 338: b1542.

55. Franken SM, Witte BI, Pavel S y Rustemeyer T, Psoriasis and daily low-emission phototherapy: effects on disease and vitamin D level, Photodermatol Photoimmunol Photomed 2015; 31(2): 83-9.

56. Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA et al., Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study, J Am Acad Dermatol 2012; 67(5): 931-8.

57. Guilhou JJ, Colette C, Monpoint S et al., Vitamin D metabolism in psoriasis before and after phototherapy, Acta Derm Venereol 1990; 70(4): 351-4, disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1977266.

58. Jing S, Photonic fabric devices for phototherapy shen. Handbook of smart textiles, 2014.